Stockscreener 앱 받기
3.08
6.67%
-0.22
시장 영업 전:
3.04
-0.04
-1.30%
전일 마감가:
$3.30
열려 있는:
$3.22
하루 거래량:
101.48K
Relative Volume:
0.03
시가총액:
$2.89M
수익:
-
순이익/손실:
$-12.88M
주가수익비율:
-0.0864
EPS:
-35.6417
순현금흐름:
$-8.79M
1주 성능:
-13.73%
1개월 성능:
-56.25%
6개월 성능:
-47.08%
1년 성능:
-83.70%
1일 변동 폭
$3.05
$3.23
1주일 범위
$3.05
$3.5995
52주 변동 폭
$2.955
$85.80
Artelo Biosciences Inc Stock (ARTL) Company Profile
명칭
Artelo Biosciences Inc
전화
858-925-7049
주소
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Compare ARTL vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
3.08 | 2.89M | 0 | -12.88M | -8.79M | -35.64 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-08 | 업그레이드 | D. Boral Capital | Hold → Buy |
| 2021-02-12 | 개시 | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc 주식(ARTL)의 최신 뉴스
Artelo Biosciences | S-3: Registration statement for specified transactions by certain issuers - Moomoo
Artelo Biosciences may offer securities up to $75 millionSEC filing - marketscreener.com
Artelo Biosciences (NASDAQ: ARTL) files $75M shelf, includes $69.29M unsold - Stock Titan
What's behind the rise in Artelo Biosciences stock? - MSN
Why did ARTL stock skyrocket over 141% pre-market today? - MSN
Avis Budget Group, Toyota Motor and other big stocks moving lower in Monday's pre-market session - MSN
Artelo Biosciences (ARTL) Partners with ScienceMachine for AI-Dr - GuruFocus
Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development - The Manila Times
Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence Leader Sciencemachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development - marketscreener.com
Why is ARTL stock soaring pre-market today? - MSN
ARTL Stock Chart | ARTELO BIOSCIENCES INC (NASDAQ:ARTL) - ChartMill
Artelo Biosciences stock soars after withdrawing SEC filing - MSN
Artelo (ARTL) Stock Fundamentals | Q4 2025: EPS Exceeds ExpectationsRetail Trader Ideas - Cổng thông tin điện tử tỉnh Tây Ninh
ARTL (Artelo Biosciences Inc.) delivers 97.5 percent positive Q4 2025 EPS surprise, but shares drop 8.64 percent today. - Cổng thông tin điện tử tỉnh Tây Ninh
What's Behind The Rise In Artelo Biosciences Stock? - Sahm
Artelo Biosciences (ARTL) Publishes Insightful Research on Pain Management - GuruFocus
Artelo (ARTL) Stock Short Interest Analysis (Smart Money Flows) 2026-04-20Community Momentum Stocks - Cổng thông tin điện tử tỉnh Lào Cai
ARTL Stock In Play As Pipeline Expands And Nasdaq Risk Eases - StocksToTrade
ARTL Stock Draws Traders As Biotech Pipeline Expands - timothysykes.com
Artelo Biosciences jumps after Nasdaq compliance update, with low-float volatility likely adding fuel - Quiver Quantitative
ARTL Stock Whipsaws As Artelo Biosciences Expands High-Risk, High-Reward Pipeline - timothysykes.com
Top movers in Monday's pre-market session - ChartMill
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Artelo Biosciences Highlights Promising Efficacy and Safety Profile of ART26.12 as a Novel Pain Treatment Ahead of Upcoming Clinical Studies - Quiver Quantitative
Artelo says non-opioid pain drug had no serious drug-related events - Stock Titan
Artelo Biosciences Inc (ARTLW) - Minichart
Artelo Biosciences (NASDAQ: ARTL) registers 9.82M shares for resale, warrants included - Stock Titan
[EFFECT] ARTELO BIOSCIENCES, INC. SEC Filing - Stock Titan
Artelo Biosciences Stock Short Interest Rises to 64.32% - Quiver Quantitative
ARTL Should I Buy - Intellectia AI
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
Aug Wrap: What is the cash position of Artelo Biosciences Inc2026 Setups & Daily Market Momentum Tracking - baoquankhu1.vn
Panic Selling: What is the cash position of Artelo Biosciences IncQuarterly Performance Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
Artelo Biosciences regains Nasdaq listing compliance By Investing.com - Investing.com Australia
Artelo Biosciences Files Offering for 9.8 Million Common Stock; Shares Tumble - marketscreener.com
9.8M Artelo Biosciences (ARTL) shares registered for resale after March 2026 PIPE - Stock Titan
Artelo Biosciences Regains Compliance With Nasdaq Listing Requirements - Moomoo
Artelo Biosciences regains Nasdaq listing compliance - Investing.com
Artelo Biosciences Regains Nasdaq Compliance and Advances Clinical Pipeline for Cancer and Pain Treatments - Minichart
Why Is ARTL Stock Soaring Pre-Market Today? - Stocktwits
Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements - The Manila Times
Artelo Biosciences regains Nasdaq compliance, subject to one-year panel monitor - TradingView — Track All Markets
Artelo Biosciences (NASDAQ: ARTL) regains full Nasdaq listing compliance - Stock Titan
Artelo Biosciences Inc (ARTL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):